Search results
-
ESMO 2024 movers – VEGF bispecifics win, TIGIT loses
ESMO 2024 movers – VEGF bispecifics win, TIGIT loses … degraders in focus Prelude led the biotech fallers, but ESMO 2024 might be better remembered for the latest collapse … September, its last day of formal presentations. ESMO 2024 risers Company Share movement* …
- 09/18/2024 - 21:46 -
ESMO 2024 – Amgen’s PRMT5 still looks lacklustre
ESMO 2024 – Amgen’s PRMT5 still looks lacklustre … 193 in phase 1/2 Triple Meeting 2023 ESMO 2024 presentation Cutoff date 1 Sep 2023 …
- 09/17/2024 - 12:26 -
ESMO 2024 – Bristol abandonment overshadows Immatics
ESMO 2024 – Bristol abandonment overshadows Immatics …
- 09/18/2024 - 16:57 -
ESMO 2024 – Torl challenges BioNTech in Claudin6
ESMO 2024 – Torl challenges BioNTech in Claudin6 … Cross-trial comparison of Claudin-6-targeted projects at ESMO 2024 BNT211 TORL-1-23 DS-9606a …
- 09/17/2024 - 12:26 -
ESMO 2024 – Bristol bucks the degrader trend
ESMO 2024 – Bristol bucks the degrader trend …
- 09/17/2024 - 12:26 -
ESMO 2024 – Astellas defends its degrader
ESMO 2024 – Astellas defends its degrader …
- 09/17/2024 - 12:27 -
ESMO 2024 – Scorpion joins Relay in the alpha club
ESMO 2024 – Scorpion joins Relay in the alpha club …
- 09/18/2024 - 21:45 -
ESMO 2024 – J&J eyes Rybrevant colorectal expansion
ESMO 2024 – J&J eyes Rybrevant colorectal expansion …
- 09/16/2024 - 12:28 -
ESMO 2024 – a role for immunotherapy in ovarian cancer
ESMO 2024 – a role for immunotherapy in ovarian cancer …
- 09/15/2024 - 21:18 -
ESMO 2024 – combos could be the way forward for CDK2
ESMO 2024 – combos could be the way forward for CDK2 … Pfizer Blueprint Medicines Presentation ESMO 2024 ESMO 2024 ASCO 2023 ASCO 2024 Study Ph1 …
- 09/15/2024 - 21:18
